Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in Glioblastoma
International Journal of Radiation Oncology*Biology*Physics · 2025-07 · 122 (3) · 592-604
DOI: 10.1016/j.ijrobp.2025.03.028 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025-07. Verfasst von Daniel Moore-Palhares und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Glioblastoma, Diffusion Magnetic Resonance Imaging, Chemoradiotherapy, Brain Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, Elekta.
Abstract (Originalsprache)
PURPOSE: Apparent diffusion coefficient (ADC) from diffusion-weighted imaging has been shown to detect early treatment response in glioblastoma. This prospective observational serial imaging study aimed to compare ADC changes in gross tumor volume (GTV) regions that developed recurrence versus those that remained recurrence-free. METHODS AND MATERIALS: Patients with glioblastoma underwent diffusion-weighted imaging at radiation planning (baseline, fraction 0), fraction 10, fraction 20, and 1 month after completing a 6-week course of chemoradiation. Recurrence was contoured at the earliest magnetic resonance imaging showing progression. The intersection of the GTV and recurrence was labeled resistant-GTV, whereas nonintersecting GTV was labeled sensitive-GTV. ADC values and percentage changes from fraction 0 were compared between these regions. RESULTS: Eighty patients were analyzed. Median absolute ADC values for resistant (0.94 μm2/ms; IQR, 0.84-1.08) and sensitive-GTV (0.93 μm2/ms; IQR, 0.87-1.13) were similar at baseline (P = .193), but statistically significant differences were observed from the start of radiation therapy. Median ADC changes from baseline for resistant- and sensitive-GTV were +2.5% versus +15.1% at fraction 10 (P < .001), +8.1% versus +23.1% at fraction 20 (P < .001), and +21.2% versus +36.4% at 1 month after completing a 6-week course of chemoradiation (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
- Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Cana…
- Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
- Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
- Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Physical Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, Canada. Electronic address: angus1.lau@sunnybrook.ca.
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
- Elekta
Zitieren
APA
Moore-Palhares, D., Lawrence, L. S. P., Myrehaug, S., Stewart, J., Detsky, J., Tseng, C. L., Chen, H., Dinakaran, D., Maralani, P., Ruschin, M., Zhang, B., Perry, J., Lim-Fat, M. J., Sahgal, A., Soliman, H., & Lau, A. Z. (2025). Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in Glioblastoma. International Journal of Radiation Oncology*Biology*Physics, 122(3), 592-604. https://doi.org/10.1016/j.ijrobp.2025.03.028
Vancouver
Moore-Palhares D, Lawrence LSP, Myrehaug S, Stewart J, Detsky J, Tseng CL, et al. Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 2025;122(3):592-604. doi:10.1016/j.ijrobp.2025.03.028
BibTeX
@article{MoorePalhares2025,
author = {Moore-Palhares, Daniel and Lawrence, Liam S P and Myrehaug, Sten and Stewart, James and Detsky, Jay and Tseng, Chia-Lin and Chen, Hanbo and Dinakaran, Deepak and Maralani, Pejman and Ruschin, Mark and Zhang, Beibei and Perry, James and Lim-Fat, Mary Jane and Sahgal, Arjun and Soliman, Hany and Lau, Angus Z},
title = {Temporal Apparent Diffusion Coefficient Changes During Chemoradiation: An Imaging Biomarker for Tumor Response Monitoring and Spatial Recurrence Prediction in Glioblastoma},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2025},
volume = {122},
number = {3},
pages = {592--604},
doi = {10.1016/j.ijrobp.2025.03.028}
}
EUVIMED